Evidence map›Paper›PMID 18829062›Full record

ArticleVirology2008

Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility.

S A Huber, M Rincon

Abstract read
In one paragraph

Article in Virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S A HuberDepartment of Pathology, University of Vermont, Colchester, VT 05446, USA. Sally.Huber@uvm.edu
M Rincon
University of Vermont · US

Funding

Synovial V delta 1 cells kill Th2 cellsP01AI045666 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BUDD, RALPH C · 1999 to 2010
$12.5M
T reg Cells in MyocarditisR01HL086549 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUBER, SALLY A · 2007 to 2010
$1.5M
Sex in MyocarditisR01HL080594 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HUBER, SALLY A · 2005 to 2008
$1.2M
NHLBI NIH HHS HL80594NHLBI NIH HHS HL86549NHLBI NIH HHS R01 HL080594NHLBI NIH HHS R01 HL086549NIAID NIH HHS AI45666NIAID NIH HHS P01 AI045666
6 · The paper itself

Abstract

Ultraviolet (u.v.) inactivated coxsackievirus B3 (CVB3) induces rapid calcium flux in naïve BALB/c CD4+ T cells. CD4+ cells lacking decay accelerating factor (DAF-/-) show little calcium flux indicating that virus cross-linking of this virus receptor protein is necessary for calcium signaling in CVB3 infection. Interaction of CVB3 with CD4+ cells also activates NFAT DNA binding. To show that NFAT activation is crucial to CVB3 induced disease, wild-type mice and transgenic mice expressing dominant-negative NFAT (dnNFAT) mutant in T cells were infected and evaluated for myocarditis and pancreatitis 7 days later. Inhibition of NFAT in T cells prevented myocarditis but had no effect on pancreatitis. Virus titers in pancreas were equivalent in wild-type and dnNFAT animals but cardiac virus titers were increased in dnNFAT mice. Interferon-gamma (IFN gamma) expression was reduced in both CD4+ and V gamma 4+ T cells from dnNFAT mice compared to controls. FasL expression by V gamma 4+ cells was also suppressed. Inhibition of FasL expression by V gamma 4+ cells is consistent with myocarditis protection in dnNFAT mice.

Indexed as

AnimalsCalciumCD4-Positive T-LymphocytesCoxsackievirus InfectionsDisease SusceptibilityEnterovirus B, HumanGene Expression RegulationMaleMiceMice, Inbred BALB CMice, KnockoutMyocarditisMyocardiumNFATC Transcription FactorsPancreasSpleenCalciumNFATC Transcription Factors

Identifiers

PMID18829062
PMCPMC2590670
OpenAlexW2084437697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.